| [1] |
Madhi SA, Dangor Z, Heath PT, et al. Considerations for a phase-Ⅲ trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants[J]. Vaccine, 2013, 31(Suppl 4): D52-D57.
|
| [2] |
Libster R, Edwards KM, Levent F, et al. Long-term outcomes of group B Streptococcal meningitis[J]. Pediatrics, 2012, 130(1): e8-e15.
|
| [3] |
Chen VL, Avci FY, Kasper DL. A maternal vaccine against group B Streptococcus: past, present, and future[J]. Vaccine, 2013, 31(Suppl 4): D13-D19.
|
| [4] |
Le Doare K, Heath PT. An overview of global GBS epidemiology[J]. Vaccine, 2013, 31(Suppl 4): D7-D12.
|
| [5] |
Nocard N, Mollareau R. Sur une mammite contagieuse des vaches laitières[J]. Ann Inst Pasteur, 1887, 1(1): 109-126.
|
| [6] |
Jannati E, Roshani M, Arzanlou M, et al. Capsular serotype and antibiotic resistance of group B Streptococci isolated from pregnant women in Ardabil, Iran[J]. Iran J Microbiol, 2012, 4(3): 130-135.
|
| [7] |
Carlin AF, Chang YC, Areschoug T, et al. Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5[J]. J Exp Med, 2009, 206(8): 1691-1699.
|
| [8] |
Da Cunha V, Davies MR, Douarre PE, et al. Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline[J]. Nat Commun, 2014, 5: 4544-4547.
|
| [9] |
Bisharat N, Crook DW, Leigh J, et al. Hyperinvasive neonatal group B Streptococcus has arisen from a bovine ancestor[J]. J Clin Microbiol, 2004, 42(5): 2161-2167.
|
| [10] |
Bohnsack JF, Whiting A, Gottschalk M, et al. Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U．S. Academic Centers from 1995 to 1999[J]. J Clin Microbiol, 2008, 46(4): 1285-1291.
|
| [11] |
Jones N, Oliver KA, Barry J, et al. Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B Streptococcus is independent of capsular serotype[J]. Clin Infect Dis, 2006, 42(7): 915-924.
|
| [12] |
Kwatra G, Cunnington MC, Merrall E, et al. Prevalence of maternal colonisation with group B Streptococcus: a systematic review and Meta-analysis[J]. Lancet Infect Dis, 2016, 16(9): 1076-1084.
|
| [13] |
苏锦珍，吴伟元，丁璐，等. 围生期孕产妇感染或定植的B族链球菌耐药情况、血清型、毒力基因及基因型分析[J/CD]. 中华妇幼临床医学杂志(电子版), 2016, 12(5): 583-589.
|
| [14] |
王茜，马良坤，宋英娜，等. 妊娠晚期B族链球菌感染的筛查方法及妊娠结局分析[J]. 中华医学杂志，2016, 96(15): 1188-1191.
|
| [15] |
蔡晓沂，钟镐镐，王秀艳，等. 快速准确的B族链球菌检测：即时荧光探针核酸扩增技术的应用[J]. 现代预防医学，2013, 40(13): 2533-2535, 2546.
|
| [16] |
陈慧慧，范建霞，陆庭嫣，等. 孕妇B族溶血性链球菌感染对母婴的影响[J]. 上海医学，2009, 32(2): 128-130.
|
| [17] |
彭兰，柴利强，陈大立，等. 孕妇孕晚期GBS定植及新生儿早发型GBS感染趋势[J]. 中国妇幼健康研究，2016, 27(1): 26-28.
|
| [18] |
王静，刘杰，王淑贞，等. 徐州地区妊娠晚期妇女感染B群链球菌的筛查情况及药物敏感性分析[J]. 国际检验医学杂志，2015, 36(20): 2963-2964, 2966.
|
| [19] |
严静静，龚敏，张军，等. 生殖道B群链球菌感染与胎膜早破的关系[J]. 中华医学杂志，2016, 96(23): 1487-1489.
|
| [20] |
吴海军，吕磊，宋柳安，等. B群链球菌在孕妇及新生儿中带菌调查及耐药性研究[J]. 重庆医科大学学报，2013, 38(10): 1234-1236.
|
| [21] |
张丽华，杨维青，张丽，等. 广东东莞地区2009—2014年围产期孕妇B群链球菌的分离与耐药性分析[J]. 中国感染与化疗杂志，2015, 15(6): 575-578.
|
| [22] |
Verani JR, McGee L, Schrag SJ, et al. Prevention of perinatal group B Streptococcal disease: revised guidelines from CDC, 2010[J]. MMWR Recomm Rep, 2010, 59(RR-10): 1-36.
|
| [23] |
Dagnew AF, Cunnington MC, Dube Q, et al. Variation in reported neonatal group B Streptococcal disease incidence in developing countries[J]. Clin Infect Dis, 2012, 55(1): 91-102.
|
| [24] |
Dangor Z, Lala SG, Cutland CL, et al. Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants[J]. PLoS One, 2015, 10(4): e0123014.
|
| [25] |
Edmond KM, Kortsalioudaki C, Scott S, et al. Group B Streptococcal disease in infants aged younger than 3 months: systematic review and Meta-analysis[J]. Lancet, 2012, 379(9815): 547-556.
|
| [26] |
Reinheimer C, Kempf VA, Wittekindt BE, et al. Group B Streptococcus infections in neonates admitted to a German NICU: emphasis on screening and adherence to pre-analytical recommendations[J]. Early Hum Dev, 2016, 103(1): 37-41.
|
| [27] |
Miyata A, Takahashi H, Kubo T, et al. Early-onset group B Streptococcal disease following culture-based screening in Japan: a single center study[J]. J Obstet Gynaecol Res, 2012, 38(8): 1052-1056.
|
| [28] |
林新祝，吴健宁，张雪芹，等. 晚孕期阴道B族链球菌定植与新生儿感染的关系[J]. 中华围产医学杂志，2016, 19(7): 491-496.
|
| [29] |
Quan V, Verani JR, Cohen C, et al. Invasive group B Streptococcal disease in South Africa: importance of surveillance methodology[J]. PLoS One, 2016, 11(4): e0152524.
|
| [30] |
高坎坎，钟华敏，梁绮华，等. B族链球菌相关疫苗的研究进展[J/CD]. 中华妇幼临床医学杂志(电子版), 2017, 13(1): 116-119.
|
| [31] |
Capan M, Mombo-Ngoma G, Akerey-Diop D, et al. Epidemiology and management of group B Streptococcal colonization during pregnancy in Africa[J]. Wien Klin Wochenschr, 2012, 124(Suppl 3): 14-16.
|
| [32] |
Eickhoff TC, Klein JO, Daly AK, et al. Neonatal sepsis and other infections due to group B beta-hemolytic Streptococci[J]. N Engl J Med, 1964, 271(10): 1221-1228.
|
| [33] |
Bedford H, de Louvois J, Halket S, et al. Meningitis in infancy in England and Wales: follow up at age 5 years[J]. BMJ, 2001，323 (7312)：533-536 .
|
| [34] |
Libster R, Edwards KM, Levent F, et al. Long-term outcomes of group B Streptococcal meningitis[J]. Pediatrics, 2012, 130(1): e8-e15.
|
| [35] |
Melin P, Efstratiou A. Group B Streptococcal epidemiology and vaccine needs in developed countries[J]. Vaccine, 2013, 31(4): D31-D42.
|
| [36] |
Johri AK, Lata H, Yadav P, et al. Epidemiology of group B Streptococcus in developing countries[J]. Vaccine, 2013, 31(4): D43-D45.
|
| [37] |
Teatero S, Ferrieri P, Martin I, et al. Serotype distribution, population structure and antimicrobial resistance of group B Streptococcus strains recovered from colonized pregnant women[J]. J Clin Microbiol, 2017, 55(2): 412-422.
|
| [38] |
Yan Y, Hu H, Lu T, et al. Investigation of serotype distribution and resistance genes profile in group B Streptococcus isolated from pregnant women: a Chinese multicenter cohort study[J]. APMIS, 2016, 124(9): 794-799.
|
| [39] |
Baker CJ, Barrett FF. Group B Streptococcal infections in infants. The importance of the various serotypes[J]. JAMA, 1974, 230(8): 1158-1160.
|
| [40] |
Teatero S, McGeer A, Low DE, et al. Characterization of invasive group B Streptococcus from the Greater Toronto Area[J]. Canada J Clin Microbiol, 2014, 52(5): 1441-1447.
|
| [41] |
Weisner AM, Johnson AP, Lamagni TL, et al. Characterization of group B Streptococci recovered from infants with invasive disease in England and Wales[J]. Clin Infect Dis, 2004, 38(9): 1203-1208.
|
| [42] |
Johri AK, Paoletti LC, Glaser P, et al. Group B Streptococcus: global incidence and vaccine development[J]. Nat Rev Microbiol, 2006, 4(12): 932-942.
|
| [43] |
Dangor Z, Kwatra G, Izu A, et al. Correlates of protection of serotype-specific capsular antibody and invasive group B Streptococcus disease in South African infants[J]. Vaccine, 2015, 33(48): 6793-6799.
|
| [44] |
Wang P, Ma Z, Tong J, et al. Serotype distribution, antimicrobial resistance, and molecular characterization of invasive group B Streptococcus isolates recovered from Chinese neonates[J]. Int J Infect Dis, 2015, 37(1): 115-118.
|
| [45] |
Creti R, Imperi M, Berardi A, et al. Neonatal group B Streptococcus infections: prevention strategies, clinical and microbiologic characteristics in 7 years of surveillance[J]. Pediatr Infect Dis J, 2017, 36(3): 256-262.
|
| [46] |
Ahmadzia HK, Heine RP. Diagnosis and management of group B Streptococcus in pregnancy[J]. Obstet Gynecol Clin North Am, 2014, 41(4): 629-647.
|
| [47] |
Hughes RG, Brocklehurst P, Steer PJ, et al. Prevention of early-onset neonatal group B Streptococcal disease: Green-top Guideline No. 36[J]. BJOG, 2017, 124(12): e280-e305.
|
| [48] |
Montagu D, Yamey G, Visconti A, et al. Where do poor women in developing countries give birth? A multi-country analysis of demographic and health survey data[J]. PLoS One, 2011, 6(2): e17155.
|